Synphen Wu, MD, PhD

About Me

I am a neuro-oncologist who cares for people with brain tumors and neurological complications of cancer. My research focus is in understanding the developmental and cellular pathways that lead to the formation of medulloblastoma, the most common malignant pediatric brain tumor. Through this work, my overarching goal is to develop more effective treatments for my patients.

Read more Read less Minus iconIcon indicating subtraction, or that the element can be closed. Plus IconIcon indicating addition, or that the element can be opened. Arrow (down) icon.An arrow icon, usually indicating that the containing element can be opened and closed.
  • Clinical Expertise: Neuro-Oncology; Neurological Complications of Cancer; Brain Tumors
  • Languages Spoken: English; Mandarin
  • Education: MD, PhD, New York University School of Medicine
  • Residencies: Neurology – Massachusetts General Hospital/Brigham and Women’s Hospital
  • Fellowships: Neuro-Oncology – Memorial Sloan Kettering Cancer Center
  • Board Certifications: Neurology

My Research

View my lab

See Synphen Wu’s laboratory
research at Memorial Sloan Kettering.

See My Colleagues


Visit PubMed for a full listing of Synphen Wu’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more